Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
about
Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisThe Role of Astrocytes in Multiple Sclerosis ProgressionLactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interactionIonic regulation of cell volume changes and cell death after ischemic stroke.HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damageGenetic variation influences glutamate concentrations in brains of patients with multiple sclerosisAge-related changes of myelin basic protein in mouse and human auditory nerve.Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptorsReduced creatine kinase B activity in multiple sclerosis normal appearing white matterLong-term gliosis and molecular changes in the cervical spinal cord of the rhesus monkey after traumatic brain injury.In vivo evidence of glutamate toxicity in multiple sclerosis.Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation.Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.New approaches in the management of multiple sclerosis.Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucomaAxoplasmic reticulum Ca(2+) release causes secondary degeneration of spinal axons.Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA.Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model.Roles of white matter in central nervous system pathophysiologies.Therapeutic potential of kainate receptors.Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAERole of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Glutamate and ATP signalling in white matter pathology.White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosisTreatment trials in progressive MS--current challenges and future directions.Multiple sclerosis: Prospects and promise.Relapsing and progressive forms of multiple sclerosis: insights from pathology.Neurotransmitter signaling in white matter.The back and forth of axonal injury and repair after stroke.In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.A recoverable state of axon injury persists for hours after spinal cord contusion in vivo.Axons get excited to death.Identification of four functional NR3B isoforms in developing white matter reveals unexpected diversity among glutamate receptors.The axonal endoplasmic reticulum: One organelle-many functions in development, maintenance, and plasticity.Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.Changes in inhibitory CA1 network in dual pathology model of epilepsy.Functional ionotropic glutamate receptors on peripheral axons and myelin.
P2860
Q26744629-3A3D5EEC-C652-44EB-AB9D-2269981A420CQ26782843-1FC271CC-7D68-40A1-BA8E-4A4F76057593Q26851808-C9474A9B-FDD0-458A-8248-A35955203598Q27691821-9B50B3B8-BF8D-4888-A924-4232A92ABE7EQ28569045-FCECCB90-2221-48B5-B9D1-A0F2F4E83BEEQ28943414-CB17DD3E-1E1F-423D-83F3-467DB23E393CQ30468649-7D173734-E3BF-405A-B4FF-F874E6E8C006Q33410173-627016C2-462D-4B32-9934-E065E6A45889Q33593127-F4F044DC-49B5-4EC0-91D3-7D01E0589308Q33841655-1621B4FE-8416-4CFE-9E74-F98F58418429Q34081836-13E05399-7479-4241-82EF-52A8CEE65EB5Q34213029-4502D575-3671-4F81-95B0-8AF650B3C74BQ34292220-E2D58D5D-6FD1-4B22-AE86-AD5EDEC20571Q34344447-0681BDD2-1BF2-4CA4-94A7-03CEE51E88EFQ34389528-0D9B036D-A0DB-4B48-9D15-4C0184076F1CQ34470829-C94F1258-053F-4019-BAEB-B280DB916AE3Q35084174-1FE054C8-6931-4C5C-AC6A-A32AB5F57AE7Q35140785-B5010CCF-5A2E-4655-9E11-06FBB49BF341Q35772761-0AFD8358-20F7-43F3-887D-7C745DF93582Q35846494-DDBB3CF4-20D5-4720-800E-75BE7CA42F82Q36199193-B94C11D3-F793-40D5-9968-17A48CD41503Q36283207-0FC53375-BF9B-45FE-AACE-CFB3E3DCE073Q36759392-EB350864-3586-4036-A3A6-585AC8AA857EQ37438390-761BCF07-8B95-4A1D-A7A0-3CF3492F514AQ37800214-5EE2178B-7B08-4648-A10A-ACD137560ABDQ37830727-D0F95184-4CEF-451C-BB75-7806ABAFE403Q37972980-36342FF6-DF89-4391-8B43-FD93D029BA37Q38125123-C62B8666-10A4-4B85-87C3-5BD388A5BC51Q38129775-E649B239-B4E6-477B-A9C8-54B3EBFCBC29Q38203770-A0ED876D-B7F3-4A39-9DA1-48C3CE99B40EQ38206164-5FAD326C-3EE3-4679-B0E8-FFE4F850D880Q38264488-0C61A1CB-92F5-47EF-B10C-086A9FB4CAC6Q40217021-DFC4F301-AB56-467E-9BC1-D9A1BF8116A3Q41686038-4A933653-E91B-4B32-A72E-31C6FD9A7A14Q42913988-CD23E80F-2B4F-48C3-95A5-CE3535EA70B7Q44172013-CD8C5C3A-1EB2-47F7-B11C-38F90D2876FDQ47405859-80C99A6B-4D56-4C92-BA61-62FF3DFF1488Q47978691-3C0CBB64-7A66-4FA9-91A7-151A825C056DQ48637007-B0D118BB-7166-41C9-B4D7-2D5303778156Q48910324-A7355149-8EED-474C-A28E-1F51B3E47A10
P2860
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
@en
type
label
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
@en
prefLabel
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
@en
P2093
P2860
P356
P1433
P1476
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
@en
P2093
Bruce D Trapp
Elaine Coderre
Gerald W Zamponi
Mohamed Ouardouz
Peter K Stys
Shameed Hameed
Xinghua Yin
P2860
P304
P356
10.1002/ANA.21539
P577
2009-02-01T00:00:00Z